Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
From iron oxides to depigmenting agents, how new research is changing tone correction Unlocking clear skin is a constant goal for patients, which is why hyperpigmentation research routinely tops JDD…
Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…
Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…
Leaves are falling and nights are getting longer — fall is here. Even if summer felt like it went by in a blink, it's important not to miss developments in…